Virpax Pharmaceuticals (NASDAQ:VRPX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Virpax Pharmaceuticals Stock (NASDAQ: VRPX) stock price, news, charts, stock research, profile.

Open	$0.33
Close	-
Volume / Avg.	269.58K / 3.35M
Day Range	$0.33 - $0.36
52 Wk Range	0.29 - 5.48
Market Cap	$2.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	4.96%
Days to Cover	1

Recent News

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Why Is Virpax Pharmaceuticals Stock Gaining On Friday?

Virpax Pharmaceuticals shares are up 59.4% after announcing an extended collaboration with NCATS to advance its NES100 pain management candidate. Virpax also announced results from a minipig Dose Range Finding study for Probudur.

Nabaparna Bhattacharya

Why Elastic Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Oct

Buy

Hold

Sell

Strong Sell

Open	$0.33
Close	-
Volume / Avg.	269.58K / 3.35M
Day Range	$0.33 - $0.36
52 Wk Range	0.29 - 5.48
Market Cap	$2.67M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	4.96%
Days to Cover	1

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Virpax Pharmaceuticals (VRPX) stock?

You can purchase shares of Virpax Pharmaceuticals (NASDAQ:VRPX) through any online brokerage.

View our list of the best stock brokerages

Who are Virpax Pharmaceuticals (VRPX) competitors?

Other companies in Virpax Pharmaceuticals’s space includes: NovaBay Pharmaceuticals (AMEX:NBY), Processa Pharma (NASDAQ:PCSA), Titan Pharma (NASDAQ:TTNP), cbdMD (AMEX:YCBD) and 60 Degrees (NASDAQ:SXTP).

What is the forecast, or price target, for Virpax Pharmaceuticals (VRPX) stock?

There is no analysis for Virpax Pharmaceuticals to provide a consensus price target.

What is the current price for Virpax Pharmaceuticals (VRPX)?

The stock price for Virpax Pharmaceuticals (NASDAQ: VRPX) is $0.3301 last updated December 18, 2024 at 1:37 PM EST.

Does Virpax Pharmaceuticals (VRPX) pay a dividend?

There are no upcoming dividends for Virpax Pharmaceuticals.

When is Virpax Pharmaceuticals (NASDAQ:VRPX) reporting earnings?

Virpax Pharmaceuticals’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is Virpax Pharmaceuticals (VRPX) going to split?

There is no upcoming split for Virpax Pharmaceuticals.

What sector and industry does Virpax Pharmaceuticals (VRPX) operate in?

Virpax Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Virpax Pharmaceuticals

Virpax Pharmaceuticals (VRPX) Forecast